Final answer:
For elective cardioversion in a patient with supraventricular tachycardia, the medication to withhold for 48 hr prior to the procedure is Digoxin, due to its negative inotropic effects.
Step-by-step explanation:
When preparing a client for elective cardioversion to treat supraventricular tachycardia (SVT), it is important to withhold certain medications that could affect the procedure. Among the options provided, Digoxin is the medication that should be withheld for 48 hours prior to cardioversion. This medication has negative inotropic properties, meaning it can decrease the force of cardiac muscle contraction, which could influence the success of cardioversion or increase the risk of complications.